Author Archive: Jason Corum

Jason was the director of web and new media with the Biotechnology Industry Organization (BIO).

Latest Posts

Five things you need to know about the state of the industry

Höhere Erträge bei Trockenheit / Improving crop yields under dry conditions

What is the state of the biotechnology industry? To find out where the it stands and what strategies you need to survive, read Ernst & Young’s 25th annual industry report, Beyond borders: global biotechnology report 2011, that was released during a super session at the 2011 BIO International Convention. What were the industry’s profits last year? What kind of companies received funding? How should you engage the regulators? What new competencies do you need to Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , ,

Evolution of Biotech Industry is a Constant


Healthcare being delivered by smartphone, homes containing treatment capabilities now only found in hospitals, groundbreaking innovations rising from the confluence of technology and science. Change is constant in the biotech industry and few industry experts know its evolution better than Steven Burrill. Burrill, CEO of Burrill and Company, presented his 25th anniversary annual report on the state of the biotech industry Biotech 2011-Life Sciences: Looking Back to See Ahead at the 2011 BIO International Convention Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Biologics & Biosimilars: What is the Science Telling Us?


Panelists from the varied backgrounds of academia, business and regulation agreed on the highest scientific standards of biosimilar regulation. Each panelist emphasized the need for the most stringent of standards in order to ensure patient safety and efficacy within the emerging biosimilars market. As Brian Liang, Executive Director of the Institute of Health Law Studies at California Western School of Law, summed it up, “the need in biosimilars is to focus on science, not cost. These are Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

Five international biotech countries to watch


Scientific American released their third annual WorldView: A Global Biotechnology Perspective at the 2011 BIO International Convention which includes a Bio Innovation Scorecard. The Scorecard reviews individual country biotechnology programs and policies aimed at growing local innovative biotechnology sectors. Based on the results of the Bio Innovation Scorecard, here’s our list of 5 biotechs to watch: 5.  Malaysia: Ranking third in the world for the best Enterprise Support of its biotech industry by Scientific American’s Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

Innovative China: Policies for the Future

China Flag

As the second largest and fastest growing market for biotechnology products, China needs no introduction.  The opportunity to heal, fuel, and feed 1.3 billion global citizens stands in clear contrast with the regulatory, financial, and political frameworks that present challenges to the life science industry’s external access to the evolving Chinese market.  On Tuesday at the 2011 BIO International Convention, a panel discussion titled “Innovative China: Policies for the Future” addressed the future of the Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,